| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.00012 | 1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 2.9e-05 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -4.3e-05 | 1 |